Determines the level of tumor necrosis factor alpha during continuous high-flux hemodialysis (CHFD) in sepsis with acute renal failure. Measurement of suppressing activity in ultrafiltrate and spent dialysate; Superiority of CHFD over standard continuous venovenous hemofiltration; Combination of adsorption and diffusion into the dialysate.